I am in Orlando Florida attending the Department of Defense Impact Conference for the Prostate Cancer Research Program (PCRP) This DOD program is among the largest funders of prostate cancer research in the world and what is important is that the funding is designed to move research ideas that are specifically designed to have a [...]
Researchers at the Medical Oncology Unit, University of Siena, Viale Bracci 11, 53100, Siena, Italy performed a randomized phase II study which compared the activity and safety of the combination docetaxel (D)/epirubicin (EPI) with the standard of care D/prednisone (P) in men with advanced castrate-resistant prostate cancer (CRPC). […]
Light the White House Blue in September 2011 is Malecare's latest prostate cancer awareness campaign. Part petition, part people's advocacy effort, Light the White House Blue has a petition and voice of the people page at http://lightthewhitehouseblue.org Sign it, today!
Tomorrow, Wednesday- March 2, I will be joining Dr. Daniel Petrylak for a number of radio interviews about prostate cancer. Dr. Petrylak is a world renowned prostate cancer researcher and clinician. He was the principal investigator in for the development of Taxotere (docetaxel). I anticipate that we will cover a number of different prostate cancer [...]
As Black History Month comes to a close for the 35th time I am left reinvigorated. The family and I went to Washington DC last week for four days to see the sights. It's one of those things that I always wanted to do but like so many things in my childhood it was just [...]